Lung Cancer Metastatic

Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

Primary Tumor Resection for M1a Stage Lung Cancer

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC

Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy

Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer

Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer

Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lung Cancer

Pembro+Chemo in Brain Mets

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer

SPSIPB vs SAPB for Thoracoscopic Surgery

Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer